Author

Sambidhan Kattel

Institution: Karius, Inc. (United States)

Observed institution: Karius, Inc. (United States)

ORCID: 0009-0003-6881-3905

Observed ORCID: 0009-0003-6881-3905

OpenAlex ID: A5093862249

Mast cell depletion and repopulation dynamics define briquilimab efficacy in a mouse model of allergic asthma

2026 · Mang Yu, Sara Ratia, et al. · Journal of Allergy and Clinical Immunology · 3

Human KIT Antibody Briquilimab Diminishes Anaphylactic Responses in Mice Expressing Chimeric Human‐Mouse KIT

2025 · Hye‐Sook Kwon, Song Eun Lee, et al. · Allergy · 3

Briquilimab, An Anti-CD117 Antibody, Prevents Cockroach Allergen Induced Allergic Asthma In Mice Expressing Chimeric Human And Mouse CD117

2024 · Mang Yu, Andrew Wells, et al. · Journal of Allergy and Clinical Immunology · 1

Briquilimab, an Anti-Human CD117 Antibody, Treats Low-Calcemic Vitamin D3 Analog MC903-Induced Dermatitis in Mouse Model Expressing Chimeric Human/Mouse CD117

2025 · Sambidhan Kattel, Sara Ratia, et al. · Journal of Allergy and Clinical Immunology

Briquilimab, an Anti-c-Kit Antibody, Induces Durable Depletion of Mast Cells (MCs) Across Multiple Tissues in Mice Expressing Chimeric Human/Mouse CD117 (c-Kit)

2025 · Song Eun Lee, Ajay Sharma, et al. · Journal of Allergy and Clinical Immunology

Briquilimab, an Anti-Human CD117 Antibody, Prevents Epicutaneous Oxazolone-Induced Features of Dermatitis in Mouse Model Expressing Chimeric Human/Mouse CD117

2025 · Andrew Wells, Sambidhan Kattel, et al. · Journal of Allergy and Clinical Immunology

Works count: 6

Citation count: 7

H-index: 2

I10-index: